Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study.

Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B.

J Clin Med. 2019 Mar 12;8(3). pii: E344. doi: 10.3390/jcm8030344.

2.

Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials.

Carl E, Witcraft SM, Kauffman BY, Gillespie EM, Becker ES, Cuijpers P, Van Ameringen M, Smits JAJ, Powers MB.

Cogn Behav Ther. 2019 Feb 14:1-21. doi: 10.1080/16506073.2018.1560358. [Epub ahead of print]

PMID:
30760112
3.

Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.

Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E, Dwyer MG, Zivadinov R.

Mult Scler. 2019 Feb 13:1352458519828667. doi: 10.1177/1352458519828667. [Epub ahead of print]

PMID:
30755085
4.

Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.

Minns S, Levihn-Coon A, Carl E, Smits JAJ, Miller W, Howard D, Papini S, Quiroz S, Lee-Furman E, Telch M, Carlbring P, Xanthopoulos D, Powers MB.

J Anxiety Disord. 2019 Jan;61:37-44. doi: 10.1016/j.janxdis.2018.12.003. Epub 2018 Dec 21.

PMID:
30580896
5.

The effects of exercise on transdiagnostic treatment targets: A meta-analytic review.

Jacquart J, Dutcher CD, Freeman SZ, Stein AT, Dinh M, Carl E, Smits JAJ.

Behav Res Ther. 2019 Apr;115:19-37. doi: 10.1016/j.brat.2018.11.007. Epub 2018 Nov 16.

PMID:
30473437
6.

Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.

Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2018 Dec;39(12):2237-2242. doi: 10.3174/ajnr.A5876. Epub 2018 Nov 22.

PMID:
30467212
7.

Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.

Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B; MS-MRIUS Study Group.

Mult Scler Relat Disord. 2019 Jan;27:65-73. doi: 10.1016/j.msard.2018.09.037. Epub 2018 Oct 3.

PMID:
30342416
8.

Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials.

Carl E, Stein AT, Levihn-Coon A, Pogue JR, Rothbaum B, Emmelkamp P, Asmundson GJG, Carlbring P, Powers MB.

J Anxiety Disord. 2019 Jan;61:27-36. doi: 10.1016/j.janxdis.2018.08.003. Epub 2018 Aug 10.

PMID:
30287083
9.

Posttraumatic stress disorder and cigarette smoking: A systematic review.

Kearns NT, Carl E, Stein AT, Vujanovic AA, Zvolensky MJ, Smits JAJ, Powers MB.

Depress Anxiety. 2018 Nov;35(11):1056-1072. doi: 10.1002/da.22828. Epub 2018 Sep 7. Review.

PMID:
30192425
10.

Caregiver expectations of recovery among persons with spinal cord injury at three and six months post-injury: A brief report.

Agtarap S, Carl E, Reynolds MC, Roden-Foreman K, Bennett M, Rainey E, Powers MB, Driver S, Warren AM.

J Spinal Cord Med. 2018 Aug 21:1-4. doi: 10.1080/10790268.2018.1508953. [Epub ahead of print]

PMID:
30129892
11.

Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.

Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B, Schweser F.

Radiology. 2018 Nov;289(2):487-496. doi: 10.1148/radiol.2018180136. Epub 2018 Jul 17.

PMID:
30015589
12.

Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.

Minns S, Levihn-Coon A, Carl E, Smits JAJ, Miller W, Howard D, Papini S, Quiroz S, Lee-Furman E, Telch M, Carlbring P, Xanthopoulos D, Powers MB.

J Anxiety Disord. 2018 Aug;58:1-7. doi: 10.1016/j.janxdis.2018.05.006. Epub 2018 Jun 4.

PMID:
29909286
13.

Jugular Venous Flow Quantification Using Doppler Sonography.

Marr K, Jakimovski D, Mancini M, Carl E, Zivadinov R.

Ultrasound Med Biol. 2018 Aug;44(8):1762-1769. doi: 10.1016/j.ultrasmedbio.2018.04.010. Epub 2018 May 18.

PMID:
29784437
14.

The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.

Zivadinov R, Tavazzi E, Hagemeier J, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B.

CNS Drugs. 2018 Aug;32(8):763-770. doi: 10.1007/s40263-018-0521-9.

PMID:
29767815
15.

Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.

Zivadinov R, Bergsland N, Hagemeier J, Carl E, Kolb H, Hojnacki D, Weinstock-Guttman B.

J Neurol Sci. 2018 May 15;388:175-181. doi: 10.1016/j.jns.2018.03.028. Epub 2018 Mar 17.

PMID:
29627017
16.

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.

Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B.

J Neurol Sci. 2018 Apr 15;387:152-156. doi: 10.1016/j.jns.2018.02.023. Epub 2018 Feb 10.

PMID:
29571854
17.

Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.

Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, Carl E, Zivadinov R, Ramanathan M.

J Altern Complement Med. 2018 Jun;24(6):596-602. doi: 10.1089/acm.2017.0268. Epub 2018 Mar 2.

PMID:
29498537
18.

An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.

Zivadinov R, Khan N, Medin J, Christoffersen P, Price J, Korn JR, Bonzani I, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B.

J Neuroimaging. 2017 May;27(3):339-347. doi: 10.1111/jon.12411. Epub 2016 Dec 5.

19.

Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.

Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG, Weinstock-Guttman B.

Eur J Neurol. 2016 Jun;23(6):1101-9. doi: 10.1111/ene.12992. Epub 2016 Mar 21.

PMID:
26998905
20.

Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.

Weinstock-Guttman B, Hagemeier J, Kavak KS, Saini V, Patrick K, Ramasamy DP, Nadeem M, Carl E, Hojnacki D, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):937-43. doi: 10.1136/jnnp-2015-312221. Epub 2016 Jan 18.

PMID:
26780938
21.

Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS.

Zivadinov R, Cerza N, Hagemeier J, Carl E, Badgett D, Ramasamy DP, Weinstock-Guttman B, Ramanathan M.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e190. doi: 10.1212/NXI.0000000000000190. eCollection 2016 Feb.

22.

Triimidosulfonates as Acute Bite-Angle Chelates: Slow Relaxation of the Magnetization in Zero Field and Hysteresis Loop of a Co(II) Complex.

Carl E, Demeshko S, Meyer F, Stalke D.

Chemistry. 2015 Jul 6;21(28):10109-15. doi: 10.1002/chem.201406083. Epub 2015 Jun 3.

PMID:
26043416
23.

A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B.

Ther Adv Neurol Disord. 2015 Mar;8(2):59-70. doi: 10.1177/1756285615572953.

24.

Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis.

Modica CM, Bergsland N, Dwyer MG, Ramasamy DP, Carl E, Zivadinov R, Benedict RH.

Mult Scler. 2016 Jan;22(1):36-42. doi: 10.1177/1352458515579443. Epub 2015 Apr 28.

PMID:
25921038
25.

Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly.

Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F.

J Neuroimmunol. 2015 Apr 15;281:44-50. doi: 10.1016/j.jneuroim.2015.03.002. Epub 2015 Mar 5.

26.

Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.

Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E, Ramasamy DP, Cherneva M, Durfee J, Bergsland N, Dwyer MG, Kolb C, Hojnacki D, Ramanathan M, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):181-7. doi: 10.1136/jnnp-2014-310051. Epub 2015 Feb 26.

PMID:
25722366
27.

Polyimido sulfur(VI) phosphanyl ligand in metal complexation.

Carl E, Stalke D.

Chemistry. 2014 Nov 24;20(48):15849-54. doi: 10.1002/chem.201404860. Epub 2014 Oct 3.

PMID:
25284488
28.

Synthesis and structural investigation of R2Si (R = Me, Ph) bridged di-N-heterocyclic carbenes.

Ghadwal RS, Reichmann SO, Carl E, Herbst-Irmer R.

Dalton Trans. 2014 Sep 28;43(36):13704-10. doi: 10.1039/c4dt01681e.

PMID:
25101953
29.

Electronic structure and slow magnetic relaxation of low-coordinate cyclic alkyl(amino) carbene stabilized iron(I) complexes.

Samuel PP, Mondal KC, Amin Sk N, Roesky HW, Carl E, Neufeld R, Stalke D, Demeshko S, Meyer F, Ungur L, Chibotaru LF, Christian J, Ramachandran V, van Tol J, Dalal NS.

J Am Chem Soc. 2014 Aug 27;136(34):11964-71. doi: 10.1021/ja5043116. Epub 2014 Aug 13.

PMID:
25072104
30.

Prospective randomized trial of venous angioplasty in MS (PREMiSe).

Siddiqui AH, Zivadinov R, Benedict RH, Karmon Y, Yu J, Hartney ML, Marr KL, Valnarov V, Kennedy CL, Ramanathan M, Ramasamy DP, Dolic K, Hojnacki DW, Carl E, Levy EI, Hopkins LN, Weinstock-Guttman B.

Neurology. 2014 Jul 29;83(5):441-9. doi: 10.1212/WNL.0000000000000638. Epub 2014 Jun 27. Erratum in: Neurology. 2014 Aug 19;83(8):773.

31.

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study.

Zivadinov R, Chin J, Horakova D, Bergsland N, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Hagemeier J, Tyblova M, Carl E, Krasensky J, Vaneckova M, Seidl Z, Dwyer MG, Havrdova E, Ramanathan M.

J Neuroimmunol. 2014 Aug 15;273(1-2):58-64. doi: 10.1016/j.jneuroim.2014.04.012. Epub 2014 Apr 30.

PMID:
24907902
32.

Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.

Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T Jr, Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2014 Oct;35(10):1916-23. doi: 10.3174/ajnr.A3969. Epub 2014 May 29.

33.

Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.

Zivadinov R, Bergsland N, Cappellani R, Hagemeier J, Melia R, Carl E, Dwyer MG, Lincoff N, Weinstock-Guttman B, Ramanathan M.

Eur J Neurol. 2014 Aug;21(8):1137-e61. doi: 10.1111/ene.12449. Epub 2014 Apr 30.

PMID:
24779967
34.

Stabilization of a cobalt-cobalt bond by two cyclic alkyl amino carbenes.

Mondal KC, Samuel PP, Roesky HW, Carl E, Herbst-Irmer R, Stalke D, Schwederski B, Kaim W, Ungur L, Chibotaru LF, Hermann M, Frenking G.

J Am Chem Soc. 2014 Feb 5;136(5):1770-3. doi: 10.1021/ja4123285. Epub 2014 Jan 24.

PMID:
24437683
35.

Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.

Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R.

J Neurol Sci. 2014 Mar 15;338(1-2):128-34. doi: 10.1016/j.jns.2013.12.031. Epub 2013 Dec 31.

PMID:
24423584
36.

Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients.

Gabelic T, Weinstock-Guttman B, Melia R, Lincoff N, Masud MW, Kennedy C, Brinar V, Ramasamy DP, Carl E, Bergsland N, Ramanathan M, Zivadinov R.

Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S49-54. doi: 10.1016/j.clineuro.2013.09.021.

PMID:
24321155
37.

Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.

Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R.

AJNR Am J Neuroradiol. 2014 May;35(5):912-9. doi: 10.3174/ajnr.A3788. Epub 2013 Dec 12.

38.

Synthesis and reactivity of a transient, terminal nitrido complex of rhodium.

Scheibel MG, Wu Y, Stückl AC, Krause L, Carl E, Stalke D, de Bruin B, Schneider S.

J Am Chem Soc. 2013 Nov 27;135(47):17719-22. doi: 10.1021/ja409764j. Epub 2013 Nov 18.

PMID:
24237321
39.

Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow.

Beggs CB, Magnano C, Shepherd SJ, Marr K, Valnarov V, Hojnacki D, Bergsland N, Belov P, Grisafi S, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R.

J Magn Reson Imaging. 2014 Nov;40(5):1215-22. doi: 10.1002/jmri.24468. Epub 2013 Nov 8.

PMID:
24214844
40.

Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.

Zivadinov R, Karmon Y, Dolic K, Hagemeier J, Marr K, Valnarov V, Kennedy CL, Hojnacki D, Carl EM, Hopkins LN, Levy EI, Weinstock-Guttman B, Siddiqui AH.

BMC Neurol. 2013 Oct 20;13:151. doi: 10.1186/1471-2377-13-151.

41.

Comparison of intravascular ultrasound with conventional venography for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency.

Karmon Y, Zivadinov R, Weinstock-Guttman B, Marr K, Valnarov V, Dolic K, Kennedy CL, Hojnacki D, Carl EM, Hagemeier J, Hopkins LN, Levy EI, Siddiqui AH.

J Vasc Interv Radiol. 2013 Oct;24(10):1487-98.e1. doi: 10.1016/j.jvir.2013.06.012. Epub 2013 Aug 14.

PMID:
23953830
42.

Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.

Benedict RH, Weinstock-Guttmam B, Marr K, Valnarov V, Kennedy C, Carl E, Brooks C, Hojnacki D, Zivadinov R.

BMC Med. 2013 Jul 18;11:167. doi: 10.1186/1741-7015-11-167.

43.

Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.

Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, Zivadinov R.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2144-51. doi: 10.3174/ajnr.A3569. Epub 2013 May 30.

44.

Thalamic atrophy is associated with development of clinically definite multiple sclerosis.

Zivadinov R, Havrdová E, Bergsland N, Tyblova M, Hagemeier J, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Carl E, Kalincik T, Horáková D.

Radiology. 2013 Sep;268(3):831-41. doi: 10.1148/radiol.13122424. Epub 2013 Apr 23.

PMID:
23613615
45.

Easy access to silicon(0) and silicon(II) compounds.

Mondal KC, Samuel PP, Tretiakov M, Singh AP, Roesky HW, Stückl AC, Niepötter B, Carl E, Wolf H, Herbst-Irmer R, Stalke D.

Inorg Chem. 2013 Apr 15;52(8):4736-43. doi: 10.1021/ic400357p. Epub 2013 Mar 25.

PMID:
23527879
46.

Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study.

Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Beggs C, Salvi F, Zamboni P.

J Vasc Interv Radiol. 2013 Jun;24(6):829-38. doi: 10.1016/j.jvir.2013.01.490. Epub 2013 Mar 21.

PMID:
23523158
47.

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.

Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1075-81. doi: 10.1136/jnnp-2012-304661. Epub 2013 Feb 5.

PMID:
23385850
48.

Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R.

Front Biosci (Elite Ed). 2013 Jan 1;5:525-32.

PMID:
23277008
49.

Heart disease, overweight, and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalities.

Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Kennedy C, Kilanowski C, Hojnacki D, Ramanathan M, Zivadinov R.

Neurol Res. 2012 Oct;34(8):819-27. doi: 10.1179/1743132812Y.0000000062.

PMID:
22971471
50.

Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R.

Mult Scler. 2013 Apr;19(5):567-76. doi: 10.1177/1352458512459289. Epub 2012 Sep 11.

PMID:
22968543

Supplemental Content

Support Center